125 related articles for article (PubMed ID: 10492622)
1. Dissolution studies on tablets of ibuprofen using chitosan.
Ilango R; Kavimani S; Jaykar B; Umamaheshwari G
Indian J Exp Biol; 1999 May; 37(5):505-8. PubMed ID: 10492622
[TBL] [Abstract][Full Text] [Related]
2. Buoyant sustained release tablets based on chitosan.
Inouye K; Machida Y; Sannan T; Nagai T
Drug Des Deliv; 1988 Feb; 2(3):165-75. PubMed ID: 2855572
[TBL] [Abstract][Full Text] [Related]
3. Use of chitosan and hydroxypropylchitosan in drug formulations to effect sustained release.
Machida Y; Nagai T; Abe M; Sannan T
Drug Des Deliv; 1986 Nov; 1(2):119-30. PubMed ID: 3509325
[TBL] [Abstract][Full Text] [Related]
4. Use of chitosan in compressed tablets of diclofenac sodium: inhibition of drug release in an acidic environment.
Sabnis S; Rege P; Block LH
Pharm Dev Technol; 1997 Aug; 2(3):243-55. PubMed ID: 9552452
[TBL] [Abstract][Full Text] [Related]
5. Formulation of a extended release tablet containing dexibuprofen.
Yi HG; Chi MH; Kim YI; Woo JS; Park ES
Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
[TBL] [Abstract][Full Text] [Related]
6. Study of the prolonged release of theopylline from polymeric matrices based on grafted chitosan with acrylamide.
Tapia C; Costa E; Terraza C; Munita AM; Yazdani-Pedram M
Pharmazie; 2002 Nov; 57(11):744-9. PubMed ID: 12611277
[TBL] [Abstract][Full Text] [Related]
7. [Sustained-release effect of the direct compressed tablet based on chitosan and Na alginate].
Yomota C; Miyazaki T; Okada S
Yakugaku Zasshi; 1994 Apr; 114(4):257-63. PubMed ID: 8201547
[TBL] [Abstract][Full Text] [Related]
8. Buoyant sustained release granules based on chitosan.
Inouye K; Machida Y; Sannan T; Nagai T
Drug Des Deliv; 1989 Jan; 4(1):55-67. PubMed ID: 2775446
[TBL] [Abstract][Full Text] [Related]
9. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of crosslinked chitosan hydrogel beads as a carrier for prolonged delivery of diclofenac sodium: in vitro and in vivo studies.
Alsarra IA
Boll Chim Farm; 2004 Dec; 143(10):359-64. PubMed ID: 15881815
[TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
[TBL] [Abstract][Full Text] [Related]
12. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
Savaşer A; Ozkan Y; Işimer A
Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
[TBL] [Abstract][Full Text] [Related]
13. Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-beta-cyclodextrin.
Corti G; Cirri M; Maestrelli F; Mennini N; Mura P
Eur J Pharm Biopharm; 2008 Feb; 68(2):303-9. PubMed ID: 17616379
[TBL] [Abstract][Full Text] [Related]
14. ["Non-solvent shock agglomeration"--technology of a new alternative method for sustained release of ibuprofen. 5. Production and evaluation of retard formulations].
Möller T; Korsatko W
Pharmazie; 2000 Feb; 55(2):114-9. PubMed ID: 10723769
[TBL] [Abstract][Full Text] [Related]
15. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-based mucoadhesive tablets for oral delivery of ibuprofen.
Sogias IA; Williams AC; Khutoryanskiy VV
Int J Pharm; 2012 Oct; 436(1-2):602-10. PubMed ID: 22842627
[TBL] [Abstract][Full Text] [Related]
17. Chitosan: a unique polysaccharide for drug delivery.
Felt O; Buri P; Gurny R
Drug Dev Ind Pharm; 1998 Nov; 24(11):979-93. PubMed ID: 9876553
[TBL] [Abstract][Full Text] [Related]
18. Accelerated stability of Ibuprofen-Eudragit RSPM sustained release tablets, IR and DSC solid stability testing.
Abdel Rahman AA; Aboutaleb AE; Stamm A; Samy EM; Abdel-Rahman SI
J Pharm Belg; 1993; 48(6):463-70. PubMed ID: 8133428
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro evaluation of three controlled release principles of 6-N-cyclohexyl-2'-O-methyladenosine.
Royce A; Li S; Weaver M; Shah U
J Control Release; 2004 May; 97(1):79-90. PubMed ID: 15147806
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
